NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-019-2005-0-PCT-02 Synergistic Effect Of TGF-beta Blockade and Immunogenic Agents on Tumors PCT PCT PCT/US06/005888 Expired
NCI E-019-2005-0-AU-03 Synergistic Effect Of TGF-beta Blockade and Immunogenic Agents on Tumors AU National Stage 2006214052 Abandoned
NIAID E-116-2006-0-US-01 Strategies for Development of Antiviral Agents and Vaccines Against Influenza US 60/774,923 Abandoned
NCI E-200-1990-4-JP-08 GENERATION OF IMMUNE RESPONSES TO PROSTATE-SPECIFIC ANTIGEN (PSA) JP DIV 2006-38681 Abandoned
NIDA E-057-2000-0-US-04 TREATMENT OF NEURAMINIDASE DISEASE WITH PROTEASE AND NEURAMINIDASE INHIBITORS US CON 11/355,257 Abandoned
NCI E-042-2006-1-US-01 Variants In Complement Regulatory Genes Predict Age-related Macular Degeneration US 60/773,478 Abandoned
NCI E-042-2006-0-US-01 Variants In Complement Regulatory Genes Predict Age-related Macular Degeneration US 60/772,989 Abandoned
NIA E-017-2004-0-US-01 Methods and Compositions Related to GHS-R Antagonist US 60/773,076 Abandoned
NCI E-042-2006-3-US-01 Variants In Complement Regulatory Genes Predict Age-related Macular Degeneration US 60/772,688 Abandoned
NCI E-018-2005-2-CA-03 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS CA National Stage 2596845 Issued
NCI E-018-2005-2-DK-13 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS DK EP 06734945.6 Issued
NCI E-018-2005-2-EP-04 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS EP National Stage 06734945.6 Issued
NCI E-018-2005-2-LI-16 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS LI EP 06734945.6 Issued
NCI E-018-2005-2-DE-12 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS DE EP 06734945.6 Issued
NCI E-018-2005-2-FR-14 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS FR EP 06734945.6 Issued
NCI E-018-2005-2-BE-10 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS BE EP 06734945.6 Issued
NCI E-018-2005-2-GB-15 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS GB EP 06734945.6 Issued
NCI E-018-2005-2-CH-11 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS CH EP 06734945.6 Issued
NCI E-018-2005-2-AU-02 DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS AU National Stage 2006213610 Issued
NCI E-018-2005-2-US-06 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS US National Stage 11/883,694 8110352 Issued PDF
NCI E-018-2005-2-PCT-01 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS PCT PCT COMB PCT/US2006/005032 Expired
NCI E-018-2005-2-EP-08 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS EP DIV 6734945.6 Abandoned
NCI E-018-2005-2-EP-07 METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS EP DIV 6734945.6 Abandoned
NCI E-295-2005-0-US-01 Staphylococcus Aureus-Derived Extracellular Adherence Protein (Eap) As A Novel Therapy Of Neuroinflammatory Disorders US 60/771,884 Abandoned
NICHD E-111-2005-0-PCT-02 Method for Identifying the Risk of Preterm Delivery PCT PCT PCT/US2006/004934 Abandoned
NEI E-185-1992-4-JP-07 PIGMENT EPITHELIUM DERIVED FACTOR: CHARACTERIZATION OF ITS NOVEL BIOLOGICAL ACTIVITY AND SEQUENCES ENCODING AND EXPRESSING THE PROTEIN JP DIV 2006-33129 Abandoned
NIEHS E-265-2006-0-JP-03 Invention Of An Agent To Assist Neuronal Regeneration After Neuronal Injury By Suppressing Glial Scar JP National Stage 2007-522283 Abandoned
NINDS E-123-2006-0-US-01 Use Of Phosphatases To Treat Glioblastomas US 60/771,163 Abandoned
NCI E-149-1995-0-US-02 An Epithelial Cell Specific Growth Factor, Keratinocyte Growth Factor (KGF) (as amended) US CON 11/346,626 Abandoned
NCI E-095-2005-0-US-01 Immunostimulatory by CpG Oligonucleotide Virus Complexes / US 60/765,225 Abandoned
NICHD E-155-2009-0-US-01 PREGNANCY BIOMARKER PROFILES, METHODS AND COMPOSITIONS RELATED THERETO US ORD 11/346,694 7790463 Issued PDF
NCI E-082-2005-2-PCT-01 SIPA-1 GENE AND SIPA-1 INHIBITOR FOR THE TREATMENT, PREVENTION, AND DIAGNOSIS OF CANCER PCT PCT COMB PCT/US2006/003672 Abandoned
NCI E-103-2005-3-BR-06 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies BR National Stage PI0607097-3 Issued
NIAID E-317-2003-0-BE-09 Accelerated Vaccination BE EP 04779743.6 Expired
NIAID E-317-2003-0-IE-15 Accelerated Vaccination IE EP 04779743.6 Expired
NIAID E-317-2003-0-DK-12 Accelerated Vaccination DK EP 04779743.6 Expired
NIAID E-317-2003-0-NL-16 Accelerated Vaccination NL EP 04779743.6 Expired
NIAID E-317-2003-0-SE-17 Accelerated Vaccination SE EP 04779743.6 Expired
NIAID E-317-2003-0-DE-11 Accelerated Vaccination DE EP 04779743.6 Expired
NIAID E-317-2003-0-FR-13 Accelerated Vaccination FR EP 04779743.6 Expired
NIAID E-317-2003-0-GB-14 Accelerated Vaccination GB EP 04779743.6 Expired
NIAID E-317-2003-0-CH-10 Accelerated Vaccination CH EP 04779743.6 Expired
NCI E-103-2005-3-CA-03 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies CA National Stage 2596698 Issued
NCI E-103-2005-3-GB-13 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies GB EP 06734177.6 Issued
NCI E-103-2005-3-DE-11 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies DE EP 06734177.6 Issued
NCI E-103-2005-3-FR-12 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies FR EP 06734177.6 Issued
NCI E-103-2005-3-EP-09 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies EP National Stage 06734177.6 Issued
NCI E-103-2005-3-IN-08 Papillomavirus L2 N-Terminal Peptides For The Induction Of Broadly Cross-Neutralizing Antibodies IN National Stage 6219/DELNP/2007 Issued
NCI E-103-2005-3-CN-07 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies CN National Stage 200680011079.1 Issued
NCI E-103-2005-3-JP-05 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies JP National Stage 2007-554194 Issued